![Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's disease - The Lancet Healthy Longevity Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's disease - The Lancet Healthy Longevity](https://www.thelancet.com/cms/asset/3ce74ea3-aae9-4d42-ad54-e07bac61a01c/gr1.jpg)
Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's disease - The Lancet Healthy Longevity
![Experimental Alzheimer's drug may have contributed to death of study participant, according to reports | CNN Experimental Alzheimer's drug may have contributed to death of study participant, according to reports | CNN](https://cdn.cnn.com/cnnnext/dam/assets/220705101512-alzheimers-disease-brain-sanjay-gupta-orig-00002103-medium-plus-169.png)
Experimental Alzheimer's drug may have contributed to death of study participant, according to reports | CNN
![Alzheimer's drug lecanemab may slow losses in memory and thinking, study says : Shots - Health News : NPR Alzheimer's drug lecanemab may slow losses in memory and thinking, study says : Shots - Health News : NPR](https://media.npr.org/assets/img/2022/11/29/ap22333720937546-349f1809f1be350adba7003a8be602b64228b5ba.jpg)
Alzheimer's drug lecanemab may slow losses in memory and thinking, study says : Shots - Health News : NPR
![Alzheimer's disease: Experimental drug Lecanemab appears to slow progression in clinical trial but raises safety concerns | CNN Alzheimer's disease: Experimental drug Lecanemab appears to slow progression in clinical trial but raises safety concerns | CNN](https://media.cnn.com/api/v1/images/stellar/prod/221129190804-alzheimers-research-stock.jpg?c=original)
Alzheimer's disease: Experimental drug Lecanemab appears to slow progression in clinical trial but raises safety concerns | CNN
![Machine learning identifies candidates for drug repurposing in Alzheimer's disease | Nature Communications Machine learning identifies candidates for drug repurposing in Alzheimer's disease | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-21330-0/MediaObjects/41467_2021_21330_Fig1_HTML.png)
Machine learning identifies candidates for drug repurposing in Alzheimer's disease | Nature Communications
![Experimental timeline for the treatment strategy of 2xTg Alzheimer's... | Download Scientific Diagram Experimental timeline for the treatment strategy of 2xTg Alzheimer's... | Download Scientific Diagram](https://www.researchgate.net/publication/331969329/figure/fig2/AS:739621877055488@1553351005101/Experimental-timeline-for-the-treatment-strategy-of-2xTg-Alzheimers-disease-AD-mice.png)
Experimental timeline for the treatment strategy of 2xTg Alzheimer's... | Download Scientific Diagram
![Alzheimer's disease: Experimental drug Lecanemab appears to slow progression in clinical trial but raises safety concerns | CNN Alzheimer's disease: Experimental drug Lecanemab appears to slow progression in clinical trial but raises safety concerns | CNN](https://cdn.cnn.com/cnnnext/dam/assets/150624151527-alzheimers-brain-super-169.jpg)
Alzheimer's disease: Experimental drug Lecanemab appears to slow progression in clinical trial but raises safety concerns | CNN
![Flow of experimental research of SCPE in the treatment of Alzheimer's... | Download Scientific Diagram Flow of experimental research of SCPE in the treatment of Alzheimer's... | Download Scientific Diagram](https://www.researchgate.net/publication/363929713/figure/fig1/AS:11431281087194473@1664472245324/Flow-of-experimental-research-of-SCPE-in-the-treatment-of-Alzheimers-disease.png)